1. Home
  2. VVOS vs RGNT Comparison

VVOS vs RGNT Comparison

Compare VVOS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

17.4M

Sector

Health Care

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.91

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VVOS
RGNT
Founded
2016
2004
Country
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
20.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
VVOS
RGNT
Price
$1.62
$3.91
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
124.1K
12.5K
Earning Date
02-23-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
80.07
N/A
EPS
N/A
N/A
Revenue
$15,031,000.00
N/A
Revenue This Year
$28.86
N/A
Revenue Next Year
$48.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.91
N/A
52 Week Low
$1.42
$3.91
52 Week High
$7.40
$8.35

Technical Indicators

Market Signals
Indicator
VVOS
RGNT
Relative Strength Index (RSI) 44.03 24.84
Support Level $1.46 $3.91
Resistance Level $1.67 $4.64
Average True Range (ATR) 0.13 0.38
MACD 0.02 -0.13
Stochastic Oscillator 45.24 4.05

Price Performance

Historical Comparison
VVOS
RGNT

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: